Xtant Medical

2014 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Bacterin to Present at the 7th Annual LD Micro Conference

11/26/14

BELGRADE, Mont., Nov. 26, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, wil...

Read More

Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference

11/17/14

BELGRADE, Mont., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, wil...

Read More

Bacterin Receives Delisting Notice From NYSE MKT

11/14/14

BELGRADE, Mont., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Com...

Read More

Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman

11/11/14

BELGRADE, Mont., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's After the Bell with Liz Claman at approximately 4:15 PM/ET on Tuesda...

Read More

Bacterin Announces Further Expansion of Its Sales Force

11/05/14

BELGRADE, Mont., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its...

Read More

Bacterin Announces Third Quarter 2014 Results

11/05/14

Company Increases Year-Over-Year Sales, Improves Margins and Reduces Loss From Operations Third Quarter Highlights: Third Quarter 2014 total revenue increased approximately 6.6% to $8.454 million from $7.930 million reported during the th...

Read More

Bacterin to Showcase New Product Line at the North American Spine Society Annual Meeting

11/04/14

BELGRADE, Mont., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced the first public presentation...

Read More

Photo Release -- Bacterin Announces New Demineralized Bone Matrix Constructs for Spine Applications

10/29/14

BELGRADE, Mont., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the release of two unique new products...

Read More

Bacterin Awarded Grant From the Montana Board of Research and Commercialization Technology

10/27/14

BELGRADE, Mont., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, has been awarded a grant from the Montana Board of Res...

Read More

Bacterin to Report Third Quarter 2014 Financial Results on November 5, 2014

10/23/14

BELGRADE, Mont., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its...

Read More

Bacterin Presents Preclinical Results of an Efficacious Antimicrobial Orthopedic Device Coating

10/22/14

BELGRADE, Mont., Oct. 22, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, presented preclinical results of a robust and efficaci...

Read More

Bacterin Announces 3Demin(TM) Cortical Fibers

10/20/14

BELGRADE, Mont., Oct. 20, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the launch of a demineralized allograf...

Read More

Bacterin International Announces Sales Team Expansion

10/16/14

Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- Bacterin announced today three senior executive additions to its hybrid sales channel. Jeff Whitaker has joined us as Regional Vice Preside...

Read More

CORRECTING AND REPLACING -- Bacterin Announces Preliminary Third Quarter 2014 Revenue

10/16/14

Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont., Oct. 16, 2014 (GLOBE NEWSWIRE) -- In a release issued on Tuesday, October 14...

Read More

Bacterin Announces Preliminary Third Quarter 2014 Revenue

10/14/14

Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont., Oct. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYS...

Read More

Bacterin CEO Dan Goldberger to be Guest on Fox Business Network's Opening Bell With Maria Bartiromo

10/02/14

BELGRADE, Mont., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE) today announced its CEO Dan Goldberger will be a guest on FOX Business Network's Opening Bell with Maria Bartiromo at approximately 10:40 AM/ET on Fri...

Read More

Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference

09/18/14

BELGRADE, Mont., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO, Dan Goldberger, w...

Read More

Bacterin Announces the Appointment of New Board Member

08/13/14

BELGRADE, Mont., Aug. 13, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of D...

Read More

Bacterin Announces Publication in The Spine Journal Featuring OsteoSelect DBM Putty

08/12/14

BELGRADE, Mont., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today The Spine Journal has publi...

Read More

Bacterin Announces Second Quarter 2014 Results

08/12/14

Second Quarter 2014 Revenues Increase Approximately 7.5% Over Second Quarter 2013 BELGRADE, Mont., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatin...

Read More

Bacterin Announces Closing of Public Offering of Common Stock

08/06/14

BELGRADE, Mont., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the completion of its previously announ...

Read More

Bacterin Announces Clinical Results on the Use of OsteoSponge(R) SC Allograft Published in The Journal of Foot & Ankle Surgery

08/05/14

BELGRADE, Mont., Aug. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE:BONE), a leader in the development of bone graft materials and bioactive coatings for medical applications, announced today that The Journal of Foot & A...

Read More

Bacterin Announces Pricing of Public Offering of Common Stock

08/01/14

BELGRADE, Mont., Aug. 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the pricing of its previously announced...

Read More

Bacterin Announces Public Offering of Common Stock

07/31/14

BELGRADE, Mont., July 31, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it intends to offer shares of its...

Read More

Bacterin to Report Second Quarter 2014 Financial Results on August 12, 2014

07/29/14

BELGRADE, Mont., July 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its...

Read More

Bacterin Announces Reverse Split of Common Stock

07/23/14

BELGRADE, Mont., July 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that a 1:10 reverse spli...

Read More

Bacterin Announces Preliminary Second Quarter 2014 Results

07/21/14

Second Quarter total revenue expected to be in the range of $8.75 million to $8.85 million, an increase of approximately 6-7% over the same period last year. BELGRADE, Mont., July 21, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, In...

Read More

Bacterin Announces the Appointment of Robert Di Silvio as President

07/01/14

BELGRADE, Mont., July 1, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announce the addition of Ro...

Read More

Bacterin to Present at the 2014 Newport Coast Securities, Inc. Annual Equity & National Sales Conference

06/10/14

BELGRADE, Mont., June 10, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo, wil...

Read More

Bacterin Announces First Quarter 2014 Results

05/06/14

Company reports record core recurring biologics revenues of $8.7 million BELGRADE, Mont.--(BUSINESS WIRE)--May 6, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolution...

Read More

Bacterin Announces the Appointment of a Vice President of Sales

05/01/14

BELGRADE, Mont.--(BUSINESS WIRE)--May 1, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announc...

Read More

Bacterin to Report First Quarter 2014 Financial Results on May 07, 2014

04/28/14

BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 28, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced tha...

Read More

Bacterin Announces Preclinical Results on the use of OsteoSelect® DBM Putty Published in The Journal of Craniofacial Surgery

04/23/14

BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 23, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announce...

Read More

Bacterin Announces Preliminary First Quarter 2014 Revenue

04/21/14

Core recurring Biologics revenues up 20% from prior year First Quarter total revenue in the range of $8.7 million to $8.9 million, an increase of approximately 7% sequentially, and 2% over the same period la...

Read More

Bacterin Announces the Addition of Two Vice Presidents

04/08/14

BELGRADE, Mont.--(BUSINESS WIRE)--Apr. 8, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, is pleased to announ...

Read More

Clinical Results on the Use of Bacterin’s OsteoSponge® for Foot and Ankle Arthrodeses Procedures Published in Orthopedics Today

03/20/14

BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 20, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announce...

Read More

Bacterin Announces Full Year 2013 Results

03/19/14

BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 19, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today reported fina...

Read More

Bacterin Announces the Launch of OsteoSTX, a Novel Biologic Product

03/13/14

BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 13, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin’s proprie...

Read More

Bacterin Secures Additional OrbiMed Financing

03/10/14

BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 10, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, announced the closi...

Read More

Bacterin Updates Presentation Time at the Canaccord Genuity Musculoskeletal Conference

03/05/14

BELGRADE, Mont.--(BUSINESS WIRE)--Mar. 5, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO...

Read More

Bacterin to Report Full Year and Fourth Quarter 2014 Financial Results on March 19, 2014

02/25/14

BELGRADE, Mont.--(BUSINESS WIRE)--Feb. 25, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced tha...

Read More

Bacterin to Present at the Canaccord Genuity Musculoskeletal Conference

02/19/14

BELGRADE, Mont.--(BUSINESS WIRE)--Feb. 19, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CE...

Read More

Bacterin to Present at the Leerink Global Healthcare Conference

02/04/14

BELGRADE, Mont.--(BUSINESS WIRE)--Feb. 4, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CEO...

Read More

Bacterin Announces Preliminary Fourth Quarter 2013 Revenue

01/23/14

Fourth Quarter Revenue in the range of $8.15 million to $8.28 million, an increase of 4% sequentially, and 1.5% over the same period last year. Fourth Quarter Biologics Revenue in the range of $8.02 million ...

Read More

Bacterin to Present at the Noble Financial Tenth Annual Equity Conference

01/15/14

BELGRADE, Mont.--(BUSINESS WIRE)--Jan. 15, 2014-- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CF...

Read More